Jiannan Guo

Title: Jiannan Guo: Innovator in Cancer Treatment

Introduction

Jiannan Guo is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on developing effective therapies for acute myeloid leukemia, a challenging form of cancer.

Latest Patents

Jiannan Guo holds a patent for "Pyrido-pyrazinyl compounds for treating acute myeloid leukemia." This invention provides compounds that exhibit kinase inhibitory activity. Specifically, the compounds have a structure represented by a specific formula, which demonstrates good inhibitory activity against various kinases, including ALK, AXL, EGFR, and FLT3. These compounds can be utilized in preparing pharmaceutical compositions aimed at treating kinase activity-related diseases, particularly acute myeloid leukemia.

Career Highlights

Jiannan Guo is associated with Cytosinlab Therapeutics Co., Ltd., where he continues to advance his research in oncology. His dedication to developing innovative treatments has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Haiping Wu and Meng Wang, who collaborate with him in his research endeavors. Their combined expertise contributes to the advancement of cancer therapies.

Conclusion

Jiannan Guo's work in developing pyrido-pyrazinyl compounds represents a significant step forward in the treatment of acute myeloid leukemia. His innovative approach and dedication to research continue to inspire advancements in cancer therapy.